Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Baxter Healthcare Corp

Baxter Healthcare Corp Recalls

All product recalls associated with Baxter Healthcare Corp.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

589

Class I (Serious)

65

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 6861–6880 of 10393 recalls

Heparin Sodium Injection (Baxter) – Subpotent Drug (2015)

Subpotent Drug; out of specification results for heparin raw material

Class IIModerate

FDAJun 3, 2015Nationwide• Baxter Healthcare Corp

Hydromorphone 15 mg/ml Solution (Compounding Pharmacy) – Sterility Risk (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Fentanyl Baclofen Intrathecal Solution (The Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

1...342 343344345 346...520

Page 344 of 520Next

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine Clonidine Solution (Compounding Pharmacy) - sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Testosterone 200 mg/ml Injection (Compounding Pharmacy) – sterility concern (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

MIC+Methylcobalamin Injectable (Compounding Pharmacy) – sterility concern (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Hydroxocobalamin Injection (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Testosterone & Estradiol Injectable (Compounding Pharmacy) – sterility risk (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Lipotropic B-12 Injection (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine Bupivacaine Solution (Compounding Pharmacy) - Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Tri-Mix ST9C Injectable (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Tri-Mix Injectable (Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Quad-Mix Injectable (Compounding Pharmacy) – sterility concern (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Hyaluronic Acid Injection (Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Collagenase Injectable (Compounding Pharmacy) – Sterility Concern (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Cholecalciferol Injectable (Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Multi-Drug Injectable (Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Fentanyl Bupivacaine Solution (Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine + Bupivacaine Solution (Compounding Pharmacy) – sterility concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America

Morphine Bupivacaine Solution (Compounding Pharmacy) – Sterility Concerns (2015)

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Class IIModerate

FDAJun 2, 2015Nationwide• The Compounding Pharmacy of America